Burzynski Research Number Of Employees vs. Current Liabilities
| BZYR Stock | USD 0.04 0.01 28.57% |
For Burzynski Research profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Burzynski Research to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Burzynski Research utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Burzynski Research's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Burzynski Research over time as well as its relative position and ranking within its peers.
Burzynski |
Burzynski Research Current Liabilities vs. Number Of Employees Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Burzynski Research's current stock value. Our valuation model uses many indicators to compare Burzynski Research value to that of its competitors to determine the firm's financial worth. Burzynski Research is rated below average in number of employees category among its peers. It is rated below average in current liabilities category among its peers creating about 18,333 of Current Liabilities per Number Of Employees. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Burzynski Research's earnings, one of the primary drivers of an investment's value.Burzynski Number Of Employees vs. Competition
Burzynski Research is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,346. Burzynski Research adds roughly 6.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Burzynski Current Liabilities vs. Number Of Employees
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Burzynski Research |
| = | 6 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Burzynski Research |
| = | 110 K |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Burzynski Current Liabilities Comparison
Burzynski Research is currently under evaluation in current liabilities category among its peers.
Burzynski Research Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Burzynski Research, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Burzynski Research will eventually generate negative long term returns. The profitability progress is the general direction of Burzynski Research's change in net profit over the period of time. It can combine multiple indicators of Burzynski Research, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas. Burzynski Research is traded on OTC Exchange in the United States.
Burzynski Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Burzynski Research. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Burzynski Research position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Burzynski Research's important profitability drivers and their relationship over time.
Use Burzynski Research in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burzynski Research position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burzynski Research will appreciate offsetting losses from the drop in the long position's value.Burzynski Research Pair Trading
Burzynski Research Pair Trading Analysis
The ability to find closely correlated positions to Burzynski Research could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burzynski Research when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burzynski Research - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burzynski Research to buy it.
The correlation of Burzynski Research is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burzynski Research moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burzynski Research moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Burzynski Research can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Burzynski Research position
In addition to having Burzynski Research in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Burzynski Pink Sheet Analysis
When running Burzynski Research's price analysis, check to measure Burzynski Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burzynski Research is operating at the current time. Most of Burzynski Research's value examination focuses on studying past and present price action to predict the probability of Burzynski Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burzynski Research's price. Additionally, you may evaluate how the addition of Burzynski Research to your portfolios can decrease your overall portfolio volatility.